Aino Karvonen | XanEdu Customization Platform
www.academicpub.com
Author: Aino Karvonen. Results. Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.
EBSCOhost | | Efficacy of Inactivated Split-Virus Influenza...
web.a.ebscohost.com
Jiri Beran,1,2,a,b Timo Vesikari,3,a Veronika Wertzova,1 Aino Karvonen,3 Karel Honegr,2 Niklas Lindblad,3. Pascale Van Belle,4 Mathieu ...
Efficacy of inactivated split-virus influenza vaccine against...
www.scienceopen.com
Authors: Karel Honegr, Mathieu Peeters, Jiri Beran, Aino Karvonen, Timo Vesikari, Veronika Wertzova, Niklas Lindblad, Bruce L. Innis, Pascale ...
RotaTeq®, a pentavalent rotavirus vaccine: Efficacy and safety ...
www.sciencegate.app
Aino Karvonen ◽. Tiina Korhonen ◽. Pierre Van Damme ◽ ... Keyword(s):. Vaccine Efficacy ◽. Rotavirus Vaccine ◽. Efficacy And Safety. › j.vac...
Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish...
www.deepdyve.com
Efficacy of the pentavalent rotavirus vaccine,. RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study. Timo Vesikari. &. Aino Karvonen. &.
Efficacy of Inactivated SpHt-Virus Influenza Vaccine - jstor
www.jstor.org
von J Beran · · Zitiert von: 66 — Jiri Beran,12ab Timo Vesikari,3a Veronika Wertzova,1 Aino Karvonen,3 Karel H on eg r,2 Niklas Lindblad,3. Pascale Van Belle,4 Mathieu Peeters,4 Bruce L. › stable
Efficacy of the pentavalent rotavirus vaccine, RotaTeq Corecore.ac.uk › download › pdf
core.ac.uk
Timo Vesikari & Aino Karvonen &. Shannon Allen Ferrante & Max Ciarlet. Received: 18 March Accepted: 3 June Published online: ...
Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish...
link.springer.com
... up to 3 years of age: the Finnish Extension Study. Timo Vesikari,; Aino Karvonen,; Shannon Allen Ferrante,; Max Ciarlet … show all 4 hide.
Original Article – Safety and Efficacy of a Pentavalent Human–Bovine...
infectonews.wordpress.com
Source: N Engl J Med Jan v N.1 p Timo Vesikari, M.D., David O. Matson, M.D., Ph.D., Penelope Dennehy, M.D., Pierre Van Damme, M.D., Ph.D.,...
Alle Infos zum Namen "Aino Karvonen"
Efficacy of Inactivated Split‐Virus Influenza Vaccine Altmetric
oxfordjournals.altmetric.com
Journal of Infectious Diseases, December · · · Jiri Beran, Timo Vesikari, Veronika Wertzova, Aino Karvonen, Karel Honegr, Niklas ... › ...
Abstract: Efficacy of An MF59 -Adjuvanted Seasonal Influenza ...
idsa.confex.com
Aino Karvonen , Novartis Vaccines and Diagnostics, Boston, MA. Dorothee Kieninger-Baum , Novartis Vaccines and Diagnostics, Boston, MA. Heinz Schmitt, MD ...
Serotype-Specific Efficacy of the Pentavalent Rotavirus ...
idsa.confex.com
Aino Karvonen, Dr1, Jody Lawrence2, Max Ciarlet2, Shannon Allen, PhD3, Timo Vesikari, Professor4 and T. Vesikari, Merck & Co., Inc. Role(s): Consultant, ... › idsa › Pa...
CiteSeerX — ORIGINAL PAPER Efficacy of the pentavalent rotavirus...
citeseerx.ist.psu.edu
by Timo Vesikari , Aino Karvonen , Shannon Allen Ferrante , Max Ciarlet , T author = {Timo Vesikari and Aino Karvonen and Shannon Allen Ferrante and Max ...
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant...
jhu.pure.elsevier.com
Aino Karvonen, James P. Watt, Katherine L O'Brien, Mark J. DiNubile, H. Fred Clark, John W. Boslego, Paul A. Offit, Penny M. Heaton.
RotaTeq: Efficacy and safety among infants in Europe | vaccines and...
centerforvaccineethicsandpolicy.net
Vaccine Volume 28, Issue 2, Pages (11 December 2009). RotaTeq®, a pentavalent rotavirus vaccine: Efficacy and safety among infants in Europe Pages Timo Vesikari, Robbin Itzler, Aino Karvonen, Tiina Korhonen, Pierre Van Damme, Ulrich Behre, Gianni Bona, Leif Gothefors, Penny M.
Verwandte Suchanfragen zu Aino Karvonen
| Jiri Beran |
Personen Vorname "Aino" (119) Name "Karvonen" (20) |
sortiert nach Relevanz / Datum